PGS Sample Set (PSS) large_stringlengths 9 9 | Polygenic Score (PGS) ID large_stringlengths 9 2.77k | Number of Individuals int64 1 5.33M | Number of Cases float64 0 389k ⌀ | Number of Controls float64 0 1.14M ⌀ | Percent of Participants Who are Male float64 0 100 ⌀ | Sample Age large_stringclasses 733
values | Broad Ancestry Category large_stringclasses 73
values | Ancestry (e.g. French, Chinese) large_stringclasses 90
values | Country of Recruitment large_stringclasses 140
values | Additional Ancestry Description large_stringclasses 131
values | Phenotype Definitions and Methods large_stringclasses 798
values | Followup Time large_stringclasses 141
values | GWAS Catalog Study ID (GCST...) large_stringclasses 8
values | Source PubMed ID (PMID) float64 1.25M 39.9M ⌀ | Source DOI large_stringclasses 13
values | Cohort(s) large_stringclasses 460
values | Additional Sample/Cohort Information large_stringclasses 245
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSS000209 | PGS000119 | 20,468 | 884 | 19,584 | 46.9 | mean:54.2;sd:15.9;unit:years | European | null | USA | null | Basal cell carcinoma: ICD9-173.01,173.11,173.21,173.31,173.41,173.51,173.61,173.71,173.81,173.91 | null | null | null | null | MGI | null |
PSS000210 | PGS000118 | 29,898 | 2,718 | 27,180 | 45.9 | mean:57.7;sd:8.1;unit:years | European | null | UK | White British Subset | PheCode 172.11 | null | null | null | null | UKB | null |
PSS000211 | PGS000118, PGS000119, PGS000120 | 149,857 | 13,624 | 136,233 | 45.9 | mean:57.7;sd:8.1;unit:years | European | null | UK | White British Subset | PheCode 172 | null | null | null | null | UKB | null |
PSS000212 | PGS000121 | 902 | null | null | 0 | mean:70.1;sd:7.0;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000212 | PGS000121 | 557 | null | null | 100 | mean:69.5;sd:5.9;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000213 | PGS000121, PGS000122 | 902 | 95 | 807 | 0 | mean:70.1;sd:7.0;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000213 | PGS000121, PGS000122 | 557 | 135 | 422 | 100 | mean:69.5;sd:5.9;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000214 | PGS000121, PGS000122 | 902 | 395 | 507 | 0 | mean:70.1;sd:7.0;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000214 | PGS000121, PGS000122 | 557 | 135 | 422 | 100 | mean:69.5;sd:5.9;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000215 | PGS000121, PGS000122 | 902 | 166 | 736 | 0 | mean:70.1;sd:7.0;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000215 | PGS000121, PGS000122 | 557 | 53 | 504 | 100 | mean:69.5;sd:5.9;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000216 | PGS000121, PGS000122 | 902 | 103 | 799 | 0 | mean:70.1;sd:7.0;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000216 | PGS000121, PGS000122 | 557 | 9 | 548 | 100 | mean:69.5;sd:5.9;unit:years | European | null | Australia | null | null | null | null | null | null | DOES | null |
PSS000217 | PGS000016 | 10,303 | 239 | 10,064 | 17.1 | null | European | null | NR | null | Phenotypic information was self-reported by the individual through an online, interactive health history tool | null | null | null | null | CG | Samples are individuals whose healthcare provider had ordered a Color Genomics multi-gene panel test |
PSS000218 | PGS000007 | 9,529 | 828 | 8,701 | 0 | null | European | null | NR | null | Phenotypic information was self-reported by the individual through an online, interactive health history tool | null | null | null | null | CG | Samples are individuals whose healthcare provider had ordered a Color Genomics multi-gene panel test |
PSS000219 | PGS000013 | 11,010 | 126 | 10,884 | 17.1 | null | European | null | NR | null | Phenotypic information was self-reported by the individual through an online, interactive health history tool | null | null | null | null | CG | Samples are individuals whose healthcare provider had ordered a Color Genomics multi-gene panel test |
PSS000220 | PGS000067 | 56,994 | 26,419 | 30,575 | 100 | null | European, East Asian, African American or Afro-Caribbean, Oceanian, Hispanic or Latin American, South Asian, African unspecified, NR | null | Australia, Belgium, Bulgaria, Canada, China, Denmark, EU, Finland, France, French West Indies, Germany, Malaysia, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, UK, USA | Combined analysis of multiple ancestries, including: European, East Asian, African American, Hawaiian, Hispanic American, South Asian, Black African, Black Caribbean, and Other (not specified) | Age of onset of aggressive prostate cancer, defined by Gleason score ≥7, PSA ≥10 ng/mL, T3-T4 stage, nodal metastases, or distant metastases | null | null | null | null | OncoArray_Prostate | List of Cohorts available from dbGaP: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001391.v1.p1 |
PSS000221 | PGS000067 | 4,437 | 1,424 | 3,013 | 100 | null | African unspecified | null | Canada, France, French West Indies, UK, USA | Subset of OncoArray_APC_onset samples. Determined from genetic PCs via FastPop | Age of onset of aggressive prostate cancer, defined by Gleason score ≥7, PSA ≥10 ng/mL, T3-T4 stage, nodal metastases, or distant metastases | null | null | null | null | OncoArray_Prostate | List of Cohorts available from dbGaP: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001391.v1.p1 |
PSS000222 | PGS000067 | 1,901 | 716 | 1,185 | 100 | null | Asian unspecified | null | Australia, Canada, China, Denmark, EU, Finland, France, Germany, Malaysia, Norway, Poland, Spain, Sweden, The Netherlands, UK, USA | Subset of OncoArray_APC_onset samples. Determined from genetic PCs via FastPop | Age of onset of aggressive prostate cancer, defined by Gleason score ≥7, PSA ≥10 ng/mL, T3-T4 stage, nodal metastases, or distant metastases | null | null | null | null | OncoArray_Prostate | List of Cohorts available from dbGaP: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001391.v1.p1 |
PSS000223 | PGS000067 | 50,656 | 24,279 | 26,377 | 100 | null | European | null | Australia, Belgium, Bulgaria, Canada, Denmark, EU, Finland, France, Germany, Malaysia, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, UK, USA | Subset of OncoArray_APC_onset samples. Determined from genetic PCs via FastPop | Age of onset of aggressive prostate cancer, defined by Gleason score ≥7, PSA ≥10 ng/mL, T3-T4 stage, nodal metastases, or distant metastases | null | null | null | null | OncoArray_Prostate | List of Cohorts available from dbGaP: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001391.v1.p1 |
PSS000224 | PGS000067 | 34,558 | 3,983 | 30,575 | 100 | mean:70.0;iqr:[63.0,76.0];unit:years | European, East Asian, African American or Afro-Caribbean, Oceanian, Hispanic or Latin American, South Asian, African unspecified, NR | null | Australia, Belgium, Bulgaria, Canada, China, Denmark, EU, Finland, France, French West Indies, Germany, Malaysia, Norway, Poland, Portugal, Spain, Sweden, The Netherlands, UK, USA | Combined analysis of multiple ancestries, including: European, East Asian, African American, Hawaiian, Hispanic American, South Asian, Black African, Black Caribbean, and Other (not specified) | Age at death due to prostate cancer. | null | null | null | null | OncoArray_Prostate | List of Cohorts available from dbGaP: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001391.v1.p1 |
PSS000225 | PGS000123 | 469 | 334 | 135 | 55.223881 | null | European | null | NR | null | null | null | null | null | null | PPMI | Both the PPMI and WUSTL datasets are available by request from the PPMI website (www.ppmi-info.org) |
PSS000226 | PGS000123 | 786 | 493 | 293 | 58.26972 | null | European | null | USA | null | null | null | null | null | null | WUSTL | Both the PPMI and WUSTL datasets are available by request from the PPMI website (www.ppmi-info.org) |
PSS000227 | PGS000013 | 544 | 40 | 504 | null | null | Asian unspecified | null | USA | null | null | null | null | null | null | VIRGO|MESA | Cases are from VIRGO, controls are from MESA |
PSS000228 | PGS000013 | 1,298 | 336 | 962 | null | null | African American or Afro-Caribbean | null | USA | null | null | null | null | null | null | VIRGO|MESA | Cases are from VIRGO, controls are from MESA |
PSS000229 | PGS000013 | 919 | 168 | 751 | null | null | Hispanic or Latin American | null | USA | null | null | null | null | null | null | VIRGO|MESA | Cases are from VIRGO, controls are from MESA |
PSS000230 | PGS000013 | 3,081 | 1,537 | 1,544 | null | null | European | null | USA | null | null | null | null | null | null | VIRGO|MESA | Cases are from VIRGO, controls are from MESA |
PSS000231 | PGS000124 | 4,672 | 1,734 | 2,938 | null | null | European | null | Australia | null | Advanced primary open-angle glaucoma | null | null | null | null | ANZRAG | Samples come from Phase 1 and Phase 2 of ANZRAG. |
PSS000232 | PGS000125 | 7,746 | 2,499 | 5,247 | 39.646269 | null | Hispanic or Latin American | Central American, Cuban, Dominican, Mexican, Puerto Rican, South American | USA | Ancestry groups were defined based on a combination of self-identified Hispanic/Latino background and genetic similarity | Individuals with T2D were defined as those with fasting time >8 h and fasting glucose levels ≥126 mg/dL, fasting ≤8 h and fasting glucose ≥200 mg/dL, post–oral glucose tolerance test glucose ≥200 mg/dL, HbA1c ≥6.5% (48 mmol/mol), or on current treatment with antihyperglycemia medications. | null | null | null | null | HCHS-SOL | null |
PSS000233 | PGS000126 | 334,880 | 4,908 | 329,972 | null | null | European | null | UK | White British subset, unrelated | Gout identified by self-report at the inclusion visit, individuals with an ICD-10 for gout (M10) in hospital admissions who did not self-report gout were excluded from the analysis. | null | null | 25,826,379 | null | UKB | null |
PSS000234 | PGS000128, PGS000131 | 1,906 | 262 | 1,644 | 37.932844 | mean:57.4;sd:7.43;unit:years | African unspecified | null | USA | null | Incident type 2 diabtes defined as fasting glucose >= 7 mmol/L, 2 hour glucose >= 11.1 mmol/L, antidiabetic medication use, or a physician diagnosis of type 2 diabetes | range:[10.0,15.0];unit:years | null | null | null | ARIC|MESA | Partial overlap with discovery GWAS |
PSS000235 | PGS000129, PGS000132 | 5,073 | 2,391 | 2,682 | 47.44727 | mean:55.6;sd:7.37;unit:years | East Asian | null | USA, Singapore | null | Incident type 2 diabtes defined as fasting glucose >= 7 mmol/L, 2 hour glucose >= 11.1 mmol/L, antidiabetic medication use, or a physician diagnosis of type 2 diabetes | range:[10.0,15.0];unit:years | null | null | null | MESA|SCHS | Partial overlap with discovery GWAS |
PSS000236 | PGS000127, PGS000130 | 37,357 | 13,145 | 24,212 | 43.472442 | mean:54.63;sd:8.27;unit:years | European | null | USA, France, Germany, Italy, The Netherlands, Spain, Sweden, UK | null | Incident type 2 diabtes defined as fasting glucose >= 7 mmol/L, 2 hour glucose >= 11.1 mmol/L, antidiabetic medication use, or a physician diagnosis of type 2 diabetes | range:[10.0,15.0];unit:years | null | null | null | ARIC|MESA|FHS|InterAct | Partial overlap with discovery GWAS |
PSS000237 | PGS000133 | 33,694 | 110 | 33,584 | 46 | mean:57.9;sd:20.0;unit:years | European | null | USA | null | Schizophrenia case subjects had two or more ICD codes included in phecode 295.1 | null | null | null | null | BioVU | Vanderbilt University Medical Center (VUMC) biobank (BioVU) |
PSS000238 | PGS000133 | 33,694 | 451 | 33,243 | 46 | mean:57.9;sd:20.0;unit:years | European | null | USA | null | Psychosis case subjects were identified with phecode 295 | null | null | null | null | BioVU | Vanderbilt University Medical Center (VUMC) biobank (BioVU) |
PSS000239 | PGS000134 | 44,436 | 211 | 44,225 | 41 | mean:60.2;sd:16.9;unit:years | European | null | USA | null | Schizophrenia case subjects had two or more ICD codes included in phecode 295.1 | null | null | null | null | MyCode | Geisinger Health System (GHS) |
PSS000240 | PGS000134 | 44,436 | 499 | 43,937 | 41 | mean:60.2;sd:16.9;unit:years | European | null | USA | null | Psychosis case subjects were identified with phecode 295 | null | null | null | null | MyCode | Geisinger Health System (GHS) |
PSS000241 | PGS000135 | 9,569 | 53 | 9,516 | 48 | mean:57.2;sd:19.8;unit:years | European | null | USA | null | Schizophrenia case subjects had two or more ICD codes included in phecode 295.1 | null | null | null | null | BioMe | BioMe Biobank at the Mount Sinai School of Medicine (MSSM) |
PSS000243 | PGS000136 | 18,461 | 148 | 18,313 | 46 | mean:58.5;sd:16.4;unit:years | European | null | USA | null | Schizophrenia case subjects had two or more ICD codes included in phecode 295.1 | null | null | null | null | PHB | Partners HealthCare System (PHS) biobank |
PSS000244 | PGS000136 | 18,461 | 385 | 18,076 | 46 | mean:58.5;sd:16.4;unit:years | European | null | USA | null | Psychosis case subjects were identified with phecode 295 | null | null | null | null | PHB | Partners HealthCare System (PHS) biobank |
PSS000245 | PGS000137 | 1,795 | 74 | 1,721 | 43 | mean:64.02;sd:8.24;unit:years | European | null | Austalia | null | null | null | null | null | null | BMES | null |
PSS000246 | PGS000137 | 965 | 72 | 893 | null | null | European | null | UK | null | MYOC p.Gln368Ter (rs74315329) carriers using imputation. Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with y... | null | null | null | null | UKB | null |
PSS000247 | PGS000137 | 3,112 | 112 | 3,000 | null | null | European | null | UK | null | ICD-10 defined Primary open-angle glaucoma (POAG) | null | null | null | null | UKB | null |
PSS000248 | PGS000137 | 3,112 | 112 | 3,000 | null | null | European | null | UK | null | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question... | null | null | null | null | UKB | null |
PSS000249 | PGS000137 | 7,033 | 192 | 6,841 | null | null | South Asian | null | UK | null | Glaucoma cases were defined as those who (i) had an ICD-10 diagnosis of ‘primary open angle glaucoma’, ‘other glaucoma’ or ‘glaucoma, unspecified’; (ii) responded ‘glaucoma’ to the question ‘Has a doctor told you that you have any of the following problems with your eyes?’; or (iii) responded ‘glaucoma’ to the question... | null | null | null | null | UKB | null |
PSS000250 | PGS000138, PGS000139, PGS000140, PGS000141, PGS000142, PGS000143, PGS000144, PGS000145 | 36,709 | 14,696 | 22,013 | null | null | European | null | Australia, Denmark, Europe, Germany, Netherlands, Scotland, Sweden, Switzerland, UK, USA | null | null | null | null | 29,700,475 | null | BOMA|CoLaus|Edinburgh|GenPOD|GenRED|i2b2|MARS|MPIP|NESDA|QIMR|RADIANT|RS|SHIP|STAR*D|TwinGene | Part of PGC29 (PMID: 29700475) |
PSS000251 | PGS000146 | 4,886 | 1,026 | 3,860 | 0 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the distal colon confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000252 | PGS000146 | 3,269 | 827 | 2,442 | 100 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the distal colon confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000253 | PGS000146 | 5,530 | 1,670 | 3,860 | 0 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the proximal colon confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000254 | PGS000146 | 3,292 | 850 | 2,442 | 100 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the proximal colon confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000255 | PGS000146 | 4,573 | 713 | 3,860 | 0 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the rectum confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000256 | PGS000146 | 3,167 | 725 | 2,442 | 100 | null | European | null | USA, Germany | null | Colorectal adenocarcinoma located in the rectum confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000257 | PGS000146 | 733 | 380 | 353 | 0 | null | European | null | USA | null | Colorectal adenocarcinoma confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000258 | PGS000146 | 1,002 | 486 | 516 | 100 | null | European | null | USA | null | Colorectal adenocarcinoma confirmed by medical records, pathology reports, or death certificate | null | null | null | null | DALS|HPFS|NHS|VITAL|WHI|DACHS | Training and test split not relevant to PGS |
PSS000259 | PGS000147 | 4,080 | 1,336 | 2,744 | 57.205882 | range:[25.0,90.0];unit:years | European | Spanish | Spain | null | null | null | null | 2,561,368 | null | MCC-Spain | null |
PSS000260 | PGS000148 | 5,500 | 2,568 | 2,932 | 0 | mean (cases):68.8;sd (cases):9.7;unit:years | European | null | USA, Germany, Australia, Israel, Canada | null | null | null | null | null | null | Hawaiian_Colo2&3|DALS|HPFS|KCCS|MCCS|MEC|MECC|NFCCR|NHS|PLCO|VITAL|WHI|CPSII|DACHS | null |
PSS000261 | PGS000148 | 4,666 | 2,307 | 2,359 | 100 | mean (cases):67.8;sd (cases):9.7;unit:years | European | null | USA, Germany, Australia, Israel, Canada | null | null | null | null | null | null | Hawaiian_Colo2&3|DALS|HPFS|KCCS|MCCS|MEC|MECC|NFCCR|NHS|PLCO|VITAL|WHI|DACHS|CPSII | null |
PSS000262 | PGS000149 | 361,543 | 1,623 | 359,920 | 45 | mean:57.0;iqr:[50.0,63.0];unit:years | European | null | UK | null | Excluding participants with prevalent cancer at recruitment colorectal cancer was defined as ICD codes: C18 (except C18.1, Appendix), C19 and C20 | null | null | null | null | UKB | Follow-up time = 1,751,445 person years |
PSS000263 | PGS000149 | 286,877 | 1,294 | 285,583 | 46 | mean:57.0;iqr:[50.0,63.0];unit:years | European | null | UK | null | Excluding participants with prevalent cancer at recruitment colorectal cancer was defined as ICD codes: C18 (except C18.1, Appendix), C19 and C20 | null | null | null | null | UKB | Follow-up time = 1,388,191 person years |
PSS000268 | PGS000150 | 1,043 | 294 | 749 | 61.744966 | range:[50.0,79.0];unit:years | European | null | Germany | null | Unselected participants of the German screening colonoscopy program are recruited by gastroenterology practices in southern Germany in this multicenter study.Colonoscopy and histology reports are collected and information from these reports is extracted independently in a standardized way by two trained investigators, ... | null | null | null | null | BLITZ | null |
PSS000269 | PGS000150 | 749 | 249 | 500 | 60.480641 | range:[50.0,79.0];unit:years | European | null | Germany | null | Unselected participants of the German screening colonoscopy program are recruited by gastroenterology practices in southern Germany in this multicenter study.Colonoscopy and histology reports are collected and information from these reports is extracted independently in a standardized way by two trained investigators, ... | null | null | null | null | BLITZ | null |
PSS000271 | PGS000151 | 3,523 | 1,316 | 2,207 | 40.84587 | mean (cases):58.34;sd (cases):12.85;unit:years | East Asian | Han Chinese | China | null | null | null | null | null | null | NCRCC | null |
PSS000272 | PGS000152 | 343 | 343 | 0 | null | mean:69.0;sd:10.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000272 | PGS000152 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000273 | PGS000153 | 827 | 827 | 0 | 0 | mean:60.0;sd:13.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000273 | PGS000153 | 7,020 | 0 | 7,020 | 0 | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000274 | PGS000154 | 387 | 387 | 0 | null | mean:68.0;sd:13.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000274 | PGS000154 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000275 | PGS000155 | 992 | 992 | 0 | null | mean:52.0;sd:16.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000275 | PGS000155 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000276 | PGS000156 | 908 | 908 | 0 | null | mean:67.0;sd:9.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000276 | PGS000156 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000277 | PGS000157 | 450 | 450 | 0 | null | mean:59.0;sd:16.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000277 | PGS000157 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000278 | PGS000158 | 531 | 531 | 0 | 0 | mean:60.0;sd:12.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000278 | PGS000158 | 7,020 | 0 | 7,020 | 0 | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000279 | PGS000159 | 163 | 163 | 0 | null | mean:66.0;sd:11.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000279 | PGS000159 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000280 | PGS000160 | 421 | 421 | 0 | 100 | mean:62.0;sd:7.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000280 | PGS000160 | 6,407 | 0 | 6,407 | 100 | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000281 | PGS000161 | 453 | 453 | 0 | null | mean:62.0;sd:12.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000281 | PGS000161 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000282 | PGS000162 | 387 | 387 | 0 | null | mean:49.0;sd:16.0;unit:years | European | null | USA | null | Primary tumor samples from TCGA | null | null | null | null | TCGA | null |
PSS000282 | PGS000162 | 13,427 | 0 | 13,427 | null | null | European | null | USA | null | null | null | null | null | null | eMERGE | null |
PSS000283 | PGS000011 | 7,814 | 1,230 | 6,584 | 45 | mean:54.0;sd:5.7;unit:years | European | null | USA | null | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | mean:18.8;unit:years | null | 2,646,917 | null | ARIC | null |
PSS000284 | PGS000011 | 4,260 | null | null | 44 | mean:69.1;sd:6.0;unit:years | European | null | USA | null | Cross-sectional analysis of baseline scores for coronary artery calcification (Agatston score) | null | null | 25,790,876 | null | BioImage | null |
PSS000285 | PGS000011 | 22,389 | 2,902 | 19,487 | 38 | mean:58.0;sd:7.7;unit:years | European | null | Sweden | null | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | mean:19.4;unit:years | null | 8,429,286 | null | MDC-CC | null |
PSS000286 | PGS000011 | 21,222 | 971 | 20,251 | 0 | mean:54.2;sd:7.1;unit:years | European | null | USA | null | Composite endpoint of either: myocardial infarction, coronary revascularization, death from coronary causes. | mean:20.5;unit:years | null | 18,070,814 | null | WGHS | null |
PSS000287 | PGS000018 | 1,319 | null | null | 69.3 | mean:68.8;sd:9.3;unit:years | European | Dutch | Netherlands | null | (i) Secondary cardiovascular events (sCVE; incl myocardial infarction, stroke, ruptured abdominal aortic aneurysm, fatal cardiac failure, percuteneous of bypass surgery, leg amputation due to cardiovascular causes, cardiovascular death), (ii) atherosclerotic carotid plaque characteristics | mean:3.0;unit:years | null | 15,678,794 | null | AEGS1 | null |
PSS000290 | PGS000163, PGS000165, PGS000167, PGS000168, PGS000172, PGS000174, PGS000175, PGS000176, PGS000177, PGS000179, PGS000182, PGS000186, PGS000187, PGS000188, PGS000191 | 2,314 | null | null | null | null | European | French Canadian | Canada | null | null | null | null | null | null | CARTaGENE | null |
PSS000291 | PGS000163, PGS000164, PGS000165, PGS000166, PGS000167, PGS000168, PGS000169, PGS000170, PGS000171, PGS000172, PGS000173, PGS000174, PGS000175, PGS000176, PGS000177, PGS000178, PGS000179, PGS000182, PGS000183, PGS000184, PGS000185, PGS000186, PGS000187, PGS000188, PGS000189, PGS000190, PGS000191 | 39,260 | null | null | null | null | European | null | UK | null | null | null | null | null | null | INTERVAL | null |
PSS000292 | PGS000192 | 4,232 | 238 | 3,994 | null | null | European | null | Sweden | null | Composite end point of cardiovascular events was defined as myocardial infarction, ischemic stroke, and death from coronary heart disease. Death from coronary heart disease was defined on the basis of codes 412 and 414 (ICD-9) or I22–I23 and I25 (ICD-10) in the Swedish Cause of Death Register. Myocardial infarction was... | median:10.6;unit:years | null | null | null | MDC | null |
PSS000294 | PGS000193 | 92,957 | 29,475 | 63,482 | 45 | range:[46.0,80.0];unit:years | European | null | U.K. | null | Participants completed an online follow-up questionnaire assessing common mental health disorders, including MDD symptoms. Phenotypes were derived from this questionnaire. Individuals with probable MDD met lifetime criteria based on their responses to questions derived from the Composite International Diagnostic Interv... | null | null | 31,969,693 | null | UKB | null |
PSS000310 | PGS000199 | 245 | 32 | 213 | 32 | null | European | null | USA | null | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:8.0;unit:years | null | null | null | PHB | null |
PSS000311 | PGS000199 | 243 | 22 | 221 | 32 | null | European | null | USA | null | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:7.0;unit:years | null | null | null | PHB | null |
PSS000312 | PGS000198 | 245 | 30 | 215 | 32 | null | European | null | USA | null | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:8.0;unit:years | null | null | null | PHB | null |
PSS000313 | PGS000198 | 243 | 22 | 221 | 32 | null | European | null | USA | null | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:7.0;unit:years | null | null | null | PHB | null |
PSS000314 | PGS000194, PGS000195 | 245 | 90 | 155 | 32 | null | European | null | USA | null | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:8.0;unit:years | null | null | null | PHB | null |
PSS000315 | PGS000194, PGS000195 | 243 | 115 | 128 | 32 | null | European | null | USA | null | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:7.0;unit:years | null | null | null | PHB | null |
PSS000316 | PGS000197 | 245 | 31 | 214 | 32 | null | European | null | USA | null | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:8.0;unit:years | null | null | null | PHB | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.